Hydroxychloroquine Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2030

Published on : May-2020 | List of Tables : 64 | List of Figures : 78 | No. of Pages : 170 | Report Code : FACT4769MR | Format :

Global Hydroxychloroquine Market Report Insights

The global hydroxychloroquine market shall expand at a CAGR of ~4% during the forecast period (2020-2030). Hydroxychloroquine is a derivative of chloroquine and was primarily used to suppress and treat acute attacks of malaria. Eventually, hydroxychloroquine emerged as an ideal medicine for treating rheumatoid arthritis and systemic lupus erythematosus. Rheumatoid arthritis is a highly prevalent disease requiring high-cost treatment in countries like the United States, France, and Germany. Due to its fewer side effects, it has become the most preferred drug over chloroquine. The current COVID-19 pandemic has given an upswing to demand for hydroxychloroquine drugs to be used as a viable treatment modality.

Hydroxycloroquine Production in India to Surge

COVID-19 has infected over three million people and resulted in over two hundred thousand deaths. Owing to the American government’s claim that hydroxychloroquine can act against the novel coronavirus, its demand has skyrocketed. Currently accounting for over one-third of the global confirmed cases, the United States is the worst affected country in the world. To counter the deadly wave of infections, the United States government has sought assistance from the Indian government to help it procure 20 million pills of hydroxychloroquine by the end of June. Hydroxychloroquine market share of India is slated to be substantial in near term. Similarly, other countries like Nepal, Sri Lanka and Bhutan have created significant demand for this drug. Attributed to above-mentioned facts the global hydroxychloroquine market is estimated to experience year on year growth of over 100% in 2020.

Hydroxychloroquine Market Regional Insights

Due to the increasing prevalence of rheumatoid arthritis and a growing number of systemic lupus erythematosus patients in the region, North America is projected to maintain its dominance in the global HCQ market throughout the forecast period. In 2019, the United States accounted for over 30% of the global systemic lupus erythematosus, thereby increasing the consumption of hydroxychloroquine during the historical period. With the United States being a leading consumer of hydroxychloroquine, North America accounted for nearly one-third of the global hydroxychloroquine market in 2019. This demand is poised to skyrocket by the end of 2020.

hcq market 02

To get in-depth COVID-19 impact insights on the regional markets of hydroxychloroquine, request for a report sample here

Hydroxychloroquine Market Leaders Leverage Production Capacities

The global hydroxychloroquine market is highly consolidated in nature, in which the top five players accounted for over half of the global sales in 2019. Alone, Sino-Western Pharmaceutical, currently accounts for over three fourth of the Chinese market share. Dr. Reddy's Laboratories, Zydus Cadila, IPCA Labs and Mylan are the other key stakeholders in the global hydroxychloroquine market.

In response to skyrocketed demand for hydroxychloroquine, market goliaths have ramped up their production capacities. For instance, Zydus Cadila has increased its production by ten times and has claimed that it can further increase if the situation demands. Laurus Labs has increased its production capacity by 5 tons per month. Similarly, Ipca Laboratories Ltd. has increased its production by 20 tons per month. Further, numerous companies like Bayer, Laurus Labs, Sun Pharma, etc. have pledged to donate millions of hydroxychloroquine tablets in their respective regions. However, due to skyrocketed demand hydroxychloroquine market price has doubled in recent weeks.

hcq market 01

To get an exhaustive overview of the hydroxychloroquine market, ask an analyst here

Analyst Viewpoint

“Burgeoning demand for hydroxychloroquine due to coronavirus outbreak is set to witness two-fold growth by the end of 2020”, says the Fact.MR analyst.

About the Report

Fact.MR published an exclusive forecast report for hydroxychloroquine market between 2020 and 2030. The foremost objective of this report on hydroxychloroquine market is to pitch spearhead insights on market scenario, demand generators and technological advancements in the hydroxychloroquine market. Also, the study on hydroxychloroquine market addresses key dynamics, which are expected to diversify the sales and future prominence of hydroxychloroquine market.

The report on hydroxychloroquine market begins with an executive overview in which product definition has been provided. The report further proceeds with taxonomy of hydroxychloroquine market elaborating on the key segments. Also, the report outlines visionary insights on dynamics hydroxychloroquine market including drivers, restraints, opportunities and trends and pricing analysis along with the key buying factors for hydroxychloroquine. Supply chain analysis and pricing analysis of hydroxychloroquine market along with the difference between hydroxychloroquine used as per applications have also been included in the report to help the readers clearly understand the product framework map in hydroxychloroquine market.

Hydroxychloroquine Market - Scope of the Report

The hydroxychloroquine market study done by Fact.MR gives exclusive information about how the market will grow during the forecast period of 2020 – 2030. The study identifies crucial trends that are determining growth of the hydroxychloroquine market. This newly published report sheds light on vital dynamics, such as drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply of hydroxychloroquine. The report primarily conveys a summary of the market, considering the present and upcoming global rheumatoid arthritis and lupus erythematosus treatment market developments to reveal striking sides relating to the adoption of hydroxychloroquine across prominent regional markets.

A detailed assessment of the market supply chain analysis, business execution, and value chain analysis across the regional markets have been provided in the report. A list of prominent companies operating in the hydroxychloroquine market, enhance the reliability of this comprehensive research study.

Hydroxychloroquine Market: Report Summary

The study offers an inclusive analysis on diverse features including demand, revenue generation, and sales by key players in the hydroxychloroquine market across the globe. A comprehensive study on the market has been done through optimistic and conservative scenarios. The analysis and estimation of price point comparison by region with the global average price has been included in this study.

Hydroxychloroquine Market: Segmentation

Fact.MR has segmented the hydroxychloroquine market on the basis of drug type, and region.

Drug Type

Region

Anti-malarial Drug

North America

Anti-rheumatic Drug

Latin America

Lupus Suppressant Drug

Europe

Anti COVID 19 Drug

Asia Pacific

Others

Middle East & Africa


“This taxonomy prepared is confidential and intended exclusively for the individual or entity with whom it is being shared. Reading, disseminating, distributing, or copying this to any party other than addressee(s) is unauthorized and prohibited.”

Hydroxychloroquine Market: Analysis on Market Size Evaluation

Existing predictions of the hydroxychloroquine market, encompassing current as well as forthcoming values estimates, analysis on region-wise demand trends, and price index have been assimilated in the report.

The market estimation at the regional and global scale of hydroxychloroquine is available in terms of value (US$ Mn) and in terms volume (Tons). A Y-o-Y growth contrast of the prominent hydroxychloroquine market segments, along with market attractiveness valuation computes have been incorporated in the report. Metrics mentioned above are also based on hydroxychloroquine types, where hydroxychloroquine witnesses a steady demand.

Hydroxychloroquine Market: Scrutinized Assessment on Regional Segments

The weighted sections have been elaborated in the report of the hydroxychloroquine market, which deliver projection on regional markets. These chapters highlight regional macros (political economic and business environment outlook), which are expected to have a momentous influence on the growth of the hydroxychloroquine market during the forecast period.

Country-specific valuation on the demand for hydroxychloroquine has been offered for each regional market, along with market scope estimates and forecast, price index, price point assessment, and impact analysis of dynamics in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Hydroxychloroquine Market: In-depth Analysis on Competitive Landscape

The report offers the competitive scenario of the hydroxychloroquine market, along with profiles of prominent companies contributing to market expansion. Essential and up-to-date data as well as information correlated to market performers, who are principally engaged in the production and supply of hydroxychloroquine, have been presented with the help of a detailed dashboard view. The market share analysis and comparison of prominent players provided in the report permits readers to take preemptive steps in advancing their businesses.

Company profiles have been combined in the report, which exert essentials such as form portfolio, along with all-inclusive SWOT analysis on each player. The company’s presence is mapped and presented through the matrix for all prominent players functioning in the hydroxychloroquine market. It offers actionable insights to readers, which helps in thoughtfully presenting market status, and predicting competition levels in the hydroxychloroquine market. Prominent companies operating in the global hydroxychloroquine market include Abcam plc, Advanz Pharma, Amneal Pharmaceuticals Inc, Bayer AG, Dr Reddy's Lab, Ipca Laboratories Ltd., Laurus Labs and Mylan.

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Fact.MR Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Risks & Trends Assessment

    3.1. COVID-19 Impact Benchmark with Previous Crisis  

        3.1.1. Change in Hydroxychloroquine Demand and Consumption Growth

        3.1.2. Before and After COVID-19 Crisis (Projected)

        3.1.3. Before and after SARS Pandemic (Actual)

        3.1.4. Before and After Sub-prime Crisis – 2008 (Actual)

        3.1.5. Change in Demand post Recovery Period (After Each Crisis)

    3.2. Impact on Market Value (US$ Mn)

        3.2.1. Likely Loss of Value in 2020

        3.2.2. Mid-term and Long Term Forecast

        3.2.3. Quarter by Quarter Dip and Recovery Assessment 

    3.3. Anticipated Demand and Value Recovery Curve

        3.3.1. Likelihood of U-Shape Recovery

        3.3.2. Likelihood of L-Shape Recovery

    3.4. Recovery Period Assessment by Key Countries

4. Market Background

    4.1. Global Rheumatoid Arthritis Market

    4.2. Global Lupus Erythematosus Market

    4.3. Global Malaria Treatment Market

    4.4. Macro-Economic Factors

        4.4.1. GDP Growth Outlook

        4.4.2. Per Capita Medicine Expenditure

        4.4.3. Pharma Expenditure by Country 

    4.5. Regulatory Framework

    4.6. Value Chain

        4.6.1. List of Raw material Suppliers

        4.6.2. List of Internationally Certified Suppliers 

        4.6.3. List of Potential Customers

    4.7. Market Dynamics

        4.7.1. Drivers

        4.7.2. Restraints

        4.7.3. Opportunities

    4.8. Forecast Factors - Relevance & Impact

5. Global Hydroxychloroquine Market Demand Analysis 2015-2019 and Forecast, 2020-2030

    5.1. Historical Market Volume (Tons) Analysis, 2015-2019

    5.2. Current and Future Market Volume (Tons) Projections, 2020-2030

    5.3. Y-o-Y Growth Trend Analysis

6. Global Hydroxychloroquine Market - Pricing Analysis

    6.1. Regional Pricing Analysis By Region 

    6.2. Pricing Break-up

    6.3. Global Average Pricing Analysis Benchmark

7. Global Hydroxychloroquine Market Demand (in Value or Size in US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030

    7.1. Historical Market Value (US$ Mn) Analysis, 2015-2019

    7.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Hydroxychloroquine Market Analysis 2015-2019 and Forecast 2020-2030, By Drug Type

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) and Volume (tons) Analysis By Drug Type, 2015 - 2019

    8.3. Current and Future Market Size (US$ Mn) and Volume (tons) Analysis and Forecast By Drug Type, 2020 - 2030

        8.3.1. Anti-Malarial Drug 

        8.3.2. Anti-Rheumatic Drug

        8.3.3. Lupus Suppressant Drug

        8.3.4. Anti COVID 19 Drug

        8.3.5. Others

    8.4. Market Attractiveness Analysis By Drug Type 

9. Global Hydroxychloroquine Market Analysis 2015-2019 and Forecast 2020-2030, by Region

    9.1. Introduction

    9.2. Historical Market Size (US$ Mn) and Volume (tons) Analysis By Region, 2015 - 2019

    9.3. Current Market Size (US$ Mn) and Volume (tons) Analysis and Forecast By Region, 2020 - 2030

        9.3.1. North America

        9.3.2. Latin America

        9.3.3. Europe

        9.3.4. Asia Pacific

        9.3.5. Middle East & Africa (MEA)

    9.4. Market Attractiveness Analysis By Region

10. North America Hydroxychloroquine Market Analysis 2015-2019 and Forecast 2020-2030

    10.1. Introduction

    10.2. Pricing Analysis

    10.3. Historical Market Size (US$ Mn) and Volume (Tons) Trend Analysis By Market Taxonomy, 2015 - 2019

    10.4. Market Size (US$ Mn) and Volume (Tons) Forecast By Market Taxonomy, 2020 - 2030

        10.4.1.  By Country

            10.4.1.1. U.S.

            10.4.1.2. Canada

        10.4.2. By Drug Type

    10.5. Market Attractiveness Analysis

        10.5.1. By Country

        10.5.2. By Drug Type

    10.6. Market Trends

    10.7. Key Market Participants - Intensity Mapping

    10.8. Drivers and Restraints - Impact Analysis

11. Latin America Hydroxychloroquine Market Analysis 2015-2019 and Forecast 2020-2030

    11.1. Introduction

    11.2. Pricing Analysis

    11.3. Historical Market Size (US$ Mn) and Volume (Tons) Trend Analysis By Market Taxonomy, 2015 - 2019

    11.4. Market Size (US$ Mn) and Volume (Tons) Forecast By Market Taxonomy, 2020 - 2030

        11.4.1.  By Country

            11.4.1.1. Brazil

            11.4.1.2. Mexico

            11.4.1.3. Rest of Latin America

        11.4.2. By Drug Type

    11.5. Market Attractiveness Analysis

        11.5.1. By Country

        11.5.2. By Drug Type

    11.6. Market Trends

    11.7. Key Market Participants - Intensity Mapping

    11.8. Drivers and Restraints - Impact Analysis

12. Europe Hydroxychloroquine Market Analysis 2015-2019 and Forecast 2020-2030

    12.1. Introduction

    12.2. Pricing Analysis

    12.3. Historical Market Size (US$ Mn) and Volume (Tons) Trend Analysis By Market Taxonomy, 2015 - 2019

    12.4. Market Size (US$ Mn) and Volume (Tons) Forecast By Market Taxonomy, 2020 - 2030

        12.4.1.  By Country

            12.4.1.1. Germany

            12.4.1.2. Italy

            12.4.1.3. France

            12.4.1.4. U.K.

            12.4.1.5. Spain

            12.4.1.6. Rest of Europe

        12.4.2. By Drug Type

    12.5. Market Attractiveness Analysis

        12.5.1. By Country

        12.5.2. By Drug Type

    12.6. Market Trends

    12.7. Key Market Participants - Intensity Mapping

    12.8. Drivers and Restraints - Impact Analysis

13. Asia Pacific Hydroxychloroquine Market Analysis 2015-2019 and Forecast 2020-2030

    13.1. Introduction

    13.2. Pricing Analysis

    13.3. Historical Market Size (US$ Mn) and Volume (Tons) Trend Analysis By Market Taxonomy, 2015 - 2019

    13.4. Market Size (US$ Mn) and Volume (Tons) Forecast By Market Taxonomy, 2020 - 2030

        13.4.1.  By Country

            13.4.1.1. China

            13.4.1.2. India

            13.4.1.3. Taiwan

            13.4.1.4. Rest of APAC

        13.4.2. By Drug Type

    13.5. Market Attractiveness Analysis

        13.5.1. By Country

        13.5.2. By Drug Type

    13.6. Market Trends

    13.7. Key Market Participants - Intensity Mapping

    13.8. Drivers and Restraints - Impact Analysis

14. Middle East & Africa Hydroxychloroquine Market Analysis 2015-2019 and Forecast 2020-2030

    14.1. Introduction

    14.2. Pricing Analysis

    14.3. Historical Market Size (US$ Mn) and Volume (Tons) Trend Analysis By Market Taxonomy, 2015 - 2019

    14.4. Market Size (US$ Mn) and Volume (Tons) Forecast By Market Taxonomy, 2020 - 2030

        14.4.1.  By Country

            14.4.1.1. GCC Countries

            14.4.1.2. Turkey

            14.4.1.3. Northern Africa

            14.4.1.4. South Africa

            14.4.1.5. Rest of MEA

        14.4.2. By Drug Type

    14.5. Market Attractiveness Analysis

        14.5.1. By Country

        14.5.2. By Drug Type

    14.6. Market Trends

    14.7. Key Market Participants - Intensity Mapping

    14.8. Drivers and Restraints - Impact Analysis

15. Key Countries Hydroxychloroquine Market Analysis 2015-2019 and Forecast 2020-2030

    15.1. Introduction

        15.1.1. Market Value Proportion Analysis, By Key Countries

        15.1.2. Global Vs. Country Growth Comparison

    15.2. U.S. Hydroxychloroquine Market Analysis

        15.2.1. Introduction

        15.2.2. Pricing Analysis

        15.2.3. Market Value Proportion Analysis by Market Taxonomy

        15.2.4. Market Volume (Tons ) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            15.2.4.1. By Drug Type

    15.3. Canada Hydroxychloroquine Market Analysis

        15.3.1. Introduction

        15.3.2. Pricing Analysis

        15.3.3. Market Value Proportion Analysis by Market Taxonomy

        15.3.4. Market Volume (Tons ) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            15.3.4.1. By Drug Type

    15.4. Mexico Hydroxychloroquine Market Analysis

        15.4.1. Introduction

        15.4.2. Pricing Analysis

        15.4.3. Market Value Proportion Analysis by Market Taxonomy

        15.4.4. Market Volume (Tons ) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            15.4.4.1. By Drug Type

    15.5. France Hydroxychloroquine Market Analysis

        15.5.1. Introduction

        15.5.2. Pricing Analysis

        15.5.3. Market Value Proportion Analysis by Market Taxonomy

        15.5.4. Market Volume (Tons ) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            15.5.4.1. By Drug Type

    15.6. Germany Hydroxychloroquine Market Analysis

        15.6.1. Introduction

        15.6.2. Pricing Analysis

        15.6.3. Market Value Proportion Analysis by Market Taxonomy

        15.6.4. Market Volume (Tons ) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            15.6.4.1. By Drug Type

    15.7. Italy Hydroxychloroquine Market Analysis

        15.7.1. Introduction

        15.7.2. Pricing Analysis

        15.7.3. Market Value Proportion Analysis by Market Taxonomy

        15.7.4. Market Volume (Tons ) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            15.7.4.1. By Drug Type

    15.8. Spain Hydroxychloroquine Market Analysis

        15.8.1. Introduction

        15.8.2. Pricing Analysis

        15.8.3. Market Value Proportion Analysis by Market Taxonomy

        15.8.4. Market Volume (Tons ) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            15.8.4.1. By Drug Type

    15.9. UK Hydroxychloroquine Market Analysis

        15.9.1. Introduction

        15.9.2. Pricing Analysis

        15.9.3. Market Value Proportion Analysis by Market Taxonomy

        15.9.4. Market Volume (Tons ) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            15.9.4.1. By Drug Type

    15.10. China Hydroxychloroquine Market Analysis

        15.10.1. Introduction

        15.10.2. Pricing Analysis

        15.10.3. Market Value Proportion Analysis by Market Taxonomy

        15.10.4. Market Volume (Tons ) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            15.10.4.1. By Drug Type

    15.11. India Hydroxychloroquine Market Analysis

        15.11.1. Introduction

        15.11.2. Pricing Analysis

        15.11.3. Market Value Proportion Analysis by Market Taxonomy

        15.11.4. Market Volume (Tons ) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            15.11.4.1. By Drug Type

    15.12. Taiwan Hydroxychloroquine Market Analysis

        15.12.1. Introduction

        15.12.2. Pricing Analysis

        15.12.3. Market Value Proportion Analysis by Market Taxonomy

        15.12.4. Market Volume (Tons ) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            15.12.4.1. By Drug Type

    15.13. Turkey Hydroxychloroquine Market Analysis

        15.13.1. Introduction

        15.13.2. Pricing Analysis

        15.13.3. Market Value Proportion Analysis by Market Taxonomy

        15.13.4. Market Volume (Tons ) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            15.13.4.1. By Drug Type

    15.14. GCC Countries Hydroxychloroquine Market Analysis

        15.14.1. Introduction

        15.14.2. Pricing Analysis

        15.14.3. Market Value Proportion Analysis by Market Taxonomy

        15.14.4. Market Volume (Tons ) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            15.14.4.1. By Drug Type

16. Market Structure Analysis

    16.1. Market Analysis by Tier of Companies (Hydroxychloroquine)

    16.2. Market Concentration

    16.3. Market Share Analysis of Top Players

    16.4. Market Presence Analysis

17. Competition Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Competition Deep Dive 

        17.3.1. Abcam plc

            17.3.1.1. Overview

            17.3.1.2. Product Portfolio

            17.3.1.3. Segmental Revenue

            17.3.1.4. Regional Revenue

            17.3.1.5. Production clusters & Capacity*

            17.3.1.6. SWOT analysis

        17.3.2. Advanz Pharma

            17.3.2.1. Overview

            17.3.2.2. Product Portfolio

            17.3.2.3. Segmental Revenue

            17.3.2.4. Regional Revenue

            17.3.2.5. Production clusters & Capacity*

            17.3.2.6. SWOT analysis

        17.3.3. Amneal Pharmaceuticals Inc

            17.3.3.1. Overview

            17.3.3.2. Product Portfolio

            17.3.3.3. Segmental Revenue

            17.3.3.4. Regional Revenue

            17.3.3.5. Production clusters & Capacity*

            17.3.3.6. SWOT analysis

        17.3.4. Bayer AG

            17.3.4.1. Overview

            17.3.4.2. Product Portfolio

            17.3.4.3. Segmental Revenue

            17.3.4.4. Regional Revenue

            17.3.4.5. Production clusters & Capacity*

            17.3.4.6. SWOT analysis

        17.3.5. Dr Reddy's Lab

            17.3.5.1. Overview

            17.3.5.2. Product Portfolio

            17.3.5.3. Segmental Revenue

            17.3.5.4. Regional Revenue

            17.3.5.5. Production clusters & Capacity*

            17.3.5.6. SWOT analysis

        17.3.6. Ipca Laboratories Ltd.

            17.3.6.1. Overview

            17.3.6.2. Product Portfolio

            17.3.6.3. Segmental Revenue

            17.3.6.4. Regional Revenue

            17.3.6.5. Production clusters & Capacity*

            17.3.6.6. SWOT analysis

        17.3.7. Laurus Labs

            17.3.7.1. Overview

            17.3.7.2. Product Portfolio

            17.3.7.3. Segmental Revenue

            17.3.7.4. Regional Revenue

            17.3.7.5. Production clusters & Capacity*

            17.3.7.6. SWOT analysis

        17.3.8. Mylan

            17.3.8.1. Overview

            17.3.8.2. Product Portfolio

            17.3.8.3. Segmental Revenue

            17.3.8.4. Regional Revenue

            17.3.8.5. Production clusters & Capacity*

            17.3.8.6. SWOT analysis

        17.3.9. Novartis AG (Sandoz)

            17.3.9.1. Overview

            17.3.9.2. Product Portfolio

            17.3.9.3. Segmental Revenue

            17.3.9.4. Regional Revenue

            17.3.9.5. Production clusters & Capacity*

            17.3.9.6. SWOT analysis

        17.3.10. Prasco Labs

            17.3.10.1. Overview

            17.3.10.2. Product Portfolio

            17.3.10.3. Segmental Revenue

            17.3.10.4. Regional Revenue

            17.3.10.5. Production clusters & Capacity*

            17.3.10.6. SWOT analysis

        17.3.11. Sun Pharma

            17.3.11.1. Overview

            17.3.11.2. Product Portfolio

            17.3.11.3. Segmental Revenue

            17.3.11.4. Regional Revenue

            17.3.11.5. Production clusters & Capacity*

            17.3.11.6. SWOT analysis

        17.3.12. Teva Pharmaceutical Industries Ltd.

            17.3.12.1. Overview

            17.3.12.2. Product Portfolio

            17.3.12.3. Segmental Revenue

            17.3.12.4. Regional Revenue

            17.3.12.5. Production clusters & Capacity*

            17.3.12.6. SWOT analysis

        17.3.13. Wallace Pharma

            17.3.13.1. Overview

            17.3.13.2. Product Portfolio

            17.3.13.3. Segmental Revenue

            17.3.13.4. Regional Revenue

            17.3.13.5. Production clusters & Capacity*

            17.3.13.6. SWOT analysis

        17.3.14. Zydus Cadila

            17.3.14.1. Overview

            17.3.14.2. Product Portfolio

            17.3.14.3. Segmental Revenue

            17.3.14.4. Regional Revenue

            17.3.14.5. Production clusters & Capacity*

            17.3.14.6. SWOT analysis

18. Assumptions and Acronyms Used

19. Research Methodology

Fact.MR offers custom research services that help clients to get specific research solutions

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Hydroxychloroquine Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2030